JBT-101
DAIT ALE09
Phase 2 small_molecule completed
Quick answer
JBT-101 for Systemic Lupus Erythematosus is a Phase 2 program (small_molecule) at Corbus Pharmaceuticals Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Corbus Pharmaceuticals Holdings
- Indication
- Systemic Lupus Erythematosus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed